Pharmaceutical Trade Association: Trump's proposed new drug pricing plan could potentially lead to pharmaceutical companies losing up to $1 trillion over the next ten years.

According to the largest trade association in the pharmaceutical industry, PhRMA estimates that Trump's proposed new drug pricing plan could cost pharmaceutical companies up to $1 trillion in losses over the next ten years. The proposal calls for aligning drug prices in medical assistance programs with lower prices in other developed countries.